The global market for Biopharmaceutical CMO and CRO was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical CMO and CRO, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharmaceutical CMO and CRO by region & country, by Type, and by Application.

The Biopharmaceutical CMO and CRO market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical CMO and CRO.

Market Segmentation

Scope of Biopharmaceutical CMO and CRO - Market Report

Report Metric	Details
Report Name	Biopharmaceutical CMO and CRO - Market
CAGR	5%
Segment by Type:	Contract Manufacturing Contract Research
Segment by Application	Biologics Manuefacturing Biosimilars Manuefacturing Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AGC Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Inno Bio Ventures Sdn Bhd, JRS PHARMA, Lonza, PRA Health Sciences, Inc., ProBioGen AG, Rentschler Biopharma SE, Samsung BioLogics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biopharmaceutical CMO and CRO manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Biopharmaceutical CMO and CRO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Biopharmaceutical CMO and CRO in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Biopharmaceutical CMO and CRO - Market report?

Ans: The main players in the Biopharmaceutical CMO and CRO - Market are AGC Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Inno Bio Ventures Sdn Bhd, JRS PHARMA, Lonza, PRA Health Sciences, Inc., ProBioGen AG, Rentschler Biopharma SE, Samsung BioLogics

What are the Application segmentation covered in the Biopharmaceutical CMO and CRO - Market report?

Ans: The Applications covered in the Biopharmaceutical CMO and CRO - Market report are Biologics Manuefacturing, Biosimilars Manuefacturing, Other

What are the Type segmentation covered in the Biopharmaceutical CMO and CRO - Market report?

Ans: The Types covered in the Biopharmaceutical CMO and CRO - Market report are Contract Manufacturing, Contract Research

1 Market Overview

1.1 Biopharmaceutical CMO and CRO Product Introduction

1.2 Global Biopharmaceutical CMO and CRO Market Size Forecast

1.3 Biopharmaceutical CMO and CRO Market Trends & Drivers

1.3.1 Biopharmaceutical CMO and CRO Industry Trends

1.3.2 Biopharmaceutical CMO and CRO Market Drivers & Opportunity

1.3.3 Biopharmaceutical CMO and CRO Market Challenges

1.3.4 Biopharmaceutical CMO and CRO Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Biopharmaceutical CMO and CRO Players Revenue Ranking (2023)

2.2 Global Biopharmaceutical CMO and CRO Revenue by Company (2019-2024)

2.3 Key Companies Biopharmaceutical CMO and CRO Manufacturing Base Distribution and Headquarters

2.4 Key Companies Biopharmaceutical CMO and CRO Product Offered

2.5 Key Companies Time to Begin Mass Production of Biopharmaceutical CMO and CRO

2.6 Biopharmaceutical CMO and CRO Market Competitive Analysis

2.6.1 Biopharmaceutical CMO and CRO Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Biopharmaceutical CMO and CRO Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Contract Manufacturing

3.1.2 Contract Research

3.2 Global Biopharmaceutical CMO and CRO Sales Value by Type

3.2.1 Global Biopharmaceutical CMO and CRO Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Biopharmaceutical CMO and CRO Sales Value, by Type (2019-2030)

3.2.3 Global Biopharmaceutical CMO and CRO Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Biologics Manuefacturing

4.1.2 Biosimilars Manuefacturing

4.1.3 Other

4.2 Global Biopharmaceutical CMO and CRO Sales Value by Application

4.2.1 Global Biopharmaceutical CMO and CRO Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Biopharmaceutical CMO and CRO Sales Value, by Application (2019-2030)

4.2.3 Global Biopharmaceutical CMO and CRO Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Biopharmaceutical CMO and CRO Sales Value by Region

5.1.1 Global Biopharmaceutical CMO and CRO Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Biopharmaceutical CMO and CRO Sales Value by Region (2019-2024)

5.1.3 Global Biopharmaceutical CMO and CRO Sales Value by Region (2025-2030)

5.1.4 Global Biopharmaceutical CMO and CRO Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Biopharmaceutical CMO and CRO Sales Value, 2019-2030

5.2.2 North America Biopharmaceutical CMO and CRO Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Biopharmaceutical CMO and CRO Sales Value, 2019-2030

5.3.2 Europe Biopharmaceutical CMO and CRO Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Biopharmaceutical CMO and CRO Sales Value, 2019-2030

5.4.2 Asia Pacific Biopharmaceutical CMO and CRO Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Biopharmaceutical CMO and CRO Sales Value, 2019-2030

5.5.2 South America Biopharmaceutical CMO and CRO Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Biopharmaceutical CMO and CRO Sales Value, 2019-2030

5.6.2 Middle East & Africa Biopharmaceutical CMO and CRO Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Biopharmaceutical CMO and CRO Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Biopharmaceutical CMO and CRO Sales Value

6.3 United States

6.3.1 United States Biopharmaceutical CMO and CRO Sales Value, 2019-2030

6.3.2 United States Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Biopharmaceutical CMO and CRO Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Biopharmaceutical CMO and CRO Sales Value, 2019-2030

6.4.2 Europe Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Biopharmaceutical CMO and CRO Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Biopharmaceutical CMO and CRO Sales Value, 2019-2030

6.5.2 China Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

6.5.3 China Biopharmaceutical CMO and CRO Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Biopharmaceutical CMO and CRO Sales Value, 2019-2030

6.6.2 Japan Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Biopharmaceutical CMO and CRO Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Biopharmaceutical CMO and CRO Sales Value, 2019-2030

6.7.2 South Korea Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Biopharmaceutical CMO and CRO Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Biopharmaceutical CMO and CRO Sales Value, 2019-2030

6.8.2 Southeast Asia Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Biopharmaceutical CMO and CRO Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Biopharmaceutical CMO and CRO Sales Value, 2019-2030

6.9.2 India Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

6.9.3 India Biopharmaceutical CMO and CRO Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AGC Biologics

7.1.1 AGC Biologics Profile

7.1.2 AGC Biologics Main Business

7.1.3 AGC Biologics Biopharmaceutical CMO and CRO Products, Services and Solutions

7.1.4 AGC Biologics Biopharmaceutical CMO and CRO Revenue (US$ Million) & (2019-2024)

7.1.5 AGC Biologics Recent Developments

7.2 Boehringer Ingelheim International GmbH

7.2.1 Boehringer Ingelheim International GmbH Profile

7.2.2 Boehringer Ingelheim International GmbH Main Business

7.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Products, Services and Solutions

7.2.4 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Revenue (US$ Million) & (2019-2024)

7.2.5 Boehringer Ingelheim International GmbH Recent Developments

7.3 FUJIFILM Diosynth Biotechnologies

7.3.1 FUJIFILM Diosynth Biotechnologies Profile

7.3.2 FUJIFILM Diosynth Biotechnologies Main Business

7.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Products, Services and Solutions

7.3.4 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Revenue (US$ Million) & (2019-2024)

7.3.5 Inno Bio Ventures Sdn Bhd Recent Developments

7.4 Inno Bio Ventures Sdn Bhd

7.4.1 Inno Bio Ventures Sdn Bhd Profile

7.4.2 Inno Bio Ventures Sdn Bhd Main Business

7.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Products, Services and Solutions

7.4.4 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Revenue (US$ Million) & (2019-2024)

7.4.5 Inno Bio Ventures Sdn Bhd Recent Developments

7.5 JRS PHARMA

7.5.1 JRS PHARMA Profile

7.5.2 JRS PHARMA Main Business

7.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Products, Services and Solutions

7.5.4 JRS PHARMA Biopharmaceutical CMO and CRO Revenue (US$ Million) & (2019-2024)

7.5.5 JRS PHARMA Recent Developments

7.6 Lonza

7.6.1 Lonza Profile

7.6.2 Lonza Main Business

7.6.3 Lonza Biopharmaceutical CMO and CRO Products, Services and Solutions

7.6.4 Lonza Biopharmaceutical CMO and CRO Revenue (US$ Million) & (2019-2024)

7.6.5 Lonza Recent Developments

7.7 PRA Health Sciences, Inc.

7.7.1 PRA Health Sciences, Inc. Profile

7.7.2 PRA Health Sciences, Inc. Main Business

7.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Products, Services and Solutions

7.7.4 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Revenue (US$ Million) & (2019-2024)

7.7.5 PRA Health Sciences, Inc. Recent Developments

7.8 ProBioGen AG

7.8.1 ProBioGen AG Profile

7.8.2 ProBioGen AG Main Business

7.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Products, Services and Solutions

7.8.4 ProBioGen AG Biopharmaceutical CMO and CRO Revenue (US$ Million) & (2019-2024)

7.8.5 ProBioGen AG Recent Developments

7.9 Rentschler Biopharma SE

7.9.1 Rentschler Biopharma SE Profile

7.9.2 Rentschler Biopharma SE Main Business

7.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Products, Services and Solutions

7.9.4 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Revenue (US$ Million) & (2019-2024)

7.9.5 Rentschler Biopharma SE Recent Developments

7.10 Samsung BioLogics

7.10.1 Samsung BioLogics Profile

7.10.2 Samsung BioLogics Main Business

7.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Products, Services and Solutions

7.10.4 Samsung BioLogics Biopharmaceutical CMO and CRO Revenue (US$ Million) & (2019-2024)

7.10.5 Samsung BioLogics Recent Developments

8 Industry Chain Analysis

8.1 Biopharmaceutical CMO and CRO Industrial Chain

8.2 Biopharmaceutical CMO and CRO Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Biopharmaceutical CMO and CRO Sales Model

8.5.2 Sales Channel

8.5.3 Biopharmaceutical CMO and CRO Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

FUJIFILM Diosynth Biotechnologies

Inno Bio Ventures Sdn Bhd

JRS Pharma

PRA Health Sciences, Inc.

Rentschler Biopharma SE

List of Tables

Table 1. Biopharmaceutical CMO and CRO Market Trends

Table 2. Biopharmaceutical CMO and CRO Market Drivers & Opportunity

Table 3. Biopharmaceutical CMO and CRO Market Challenges

Table 4. Biopharmaceutical CMO and CRO Market Restraints

Table 5. Global Biopharmaceutical CMO and CRO Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Biopharmaceutical CMO and CRO Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Biopharmaceutical CMO and CRO Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Biopharmaceutical CMO and CRO Product Type

Table 9. Key Companies Time to Begin Mass Production of Biopharmaceutical CMO and CRO

Table 10. Global Biopharmaceutical CMO and CRO Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Biopharmaceutical CMO and CRO Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Biopharmaceutical CMO and CRO Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Biopharmaceutical CMO and CRO Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Biopharmaceutical CMO and CRO Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Biopharmaceutical CMO and CRO Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Biopharmaceutical CMO and CRO Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Biopharmaceutical CMO and CRO Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Biopharmaceutical CMO and CRO Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Biopharmaceutical CMO and CRO Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Biopharmaceutical CMO and CRO Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Biopharmaceutical CMO and CRO Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Biopharmaceutical CMO and CRO Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Biopharmaceutical CMO and CRO Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Biopharmaceutical CMO and CRO Sales Value by Region (2019-2024) & (%)

Table 27. Global Biopharmaceutical CMO and CRO Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Biopharmaceutical CMO and CRO Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Biopharmaceutical CMO and CRO Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Biopharmaceutical CMO and CRO Sales Value, (2025-2030) & (US$ Million)

Table 31. AGC Biologics Basic Information List

Table 32. AGC Biologics Description and Business Overview

Table 33. AGC Biologics Biopharmaceutical CMO and CRO Products, Services and Solutions

Table 34. Revenue (US$ Million) in Biopharmaceutical CMO and CRO Business of AGC Biologics (2019-2024)

Table 35. AGC Biologics Recent Developments

Table 36. Boehringer Ingelheim International GmbH Basic Information List

Table 37. Boehringer Ingelheim International GmbH Description and Business Overview

Table 38. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Products, Services and Solutions

Table 39. Revenue (US$ Million) in Biopharmaceutical CMO and CRO Business of Boehringer Ingelheim International GmbH (2019-2024)

Table 40. Boehringer Ingelheim International GmbH Recent Developments

Table 41. FUJIFILM Diosynth Biotechnologies Basic Information List

Table 42. FUJIFILM Diosynth Biotechnologies Description and Business Overview

Table 43. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Products, Services and Solutions

Table 44. Revenue (US$ Million) in Biopharmaceutical CMO and CRO Business of FUJIFILM Diosynth Biotechnologies (2019-2024)

Table 45. FUJIFILM Diosynth Biotechnologies Recent Developments

Table 46. Inno Bio Ventures Sdn Bhd Basic Information List

Table 47. Inno Bio Ventures Sdn Bhd Description and Business Overview

Table 48. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Products, Services and Solutions

Table 49. Revenue (US$ Million) in Biopharmaceutical CMO and CRO Business of Inno Bio Ventures Sdn Bhd (2019-2024)

Table 50. Inno Bio Ventures Sdn Bhd Recent Developments

Table 51. JRS PHARMA Basic Information List

Table 52. JRS PHARMA Description and Business Overview

Table 53. JRS PHARMA Biopharmaceutical CMO and CRO Products, Services and Solutions

Table 54. Revenue (US$ Million) in Biopharmaceutical CMO and CRO Business of JRS PHARMA (2019-2024)

Table 55. JRS PHARMA Recent Developments

Table 56. Lonza Basic Information List

Table 57. Lonza Description and Business Overview

Table 58. Lonza Biopharmaceutical CMO and CRO Products, Services and Solutions

Table 59. Revenue (US$ Million) in Biopharmaceutical CMO and CRO Business of Lonza (2019-2024)

Table 60. Lonza Recent Developments

Table 61. PRA Health Sciences, Inc. Basic Information List

Table 62. PRA Health Sciences, Inc. Description and Business Overview

Table 63. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Products, Services and Solutions

Table 64. Revenue (US$ Million) in Biopharmaceutical CMO and CRO Business of PRA Health Sciences, Inc. (2019-2024)

Table 65. PRA Health Sciences, Inc. Recent Developments

Table 66. ProBioGen AG Basic Information List

Table 67. ProBioGen AG Description and Business Overview

Table 68. ProBioGen AG Biopharmaceutical CMO and CRO Products, Services and Solutions

Table 69. Revenue (US$ Million) in Biopharmaceutical CMO and CRO Business of ProBioGen AG (2019-2024)

Table 70. ProBioGen AG Recent Developments

Table 71. Rentschler Biopharma SE Basic Information List

Table 72. Rentschler Biopharma SE Description and Business Overview

Table 73. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Products, Services and Solutions

Table 74. Revenue (US$ Million) in Biopharmaceutical CMO and CRO Business of Rentschler Biopharma SE (2019-2024)

Table 75. Rentschler Biopharma SE Recent Developments

Table 76. Samsung BioLogics Basic Information List

Table 77. Samsung BioLogics Description and Business Overview

Table 78. Samsung BioLogics Biopharmaceutical CMO and CRO Products, Services and Solutions

Table 79. Revenue (US$ Million) in Biopharmaceutical CMO and CRO Business of Samsung BioLogics (2019-2024)

Table 80. Samsung BioLogics Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Biopharmaceutical CMO and CRO Downstream Customers

Table 84. Biopharmaceutical CMO and CRO Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Biopharmaceutical CMO and CRO Product Picture

Figure 2. Global Biopharmaceutical CMO and CRO Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Biopharmaceutical CMO and CRO Sales Value (2019-2030) & (US$ Million)

Figure 4. Biopharmaceutical CMO and CRO Report Years Considered

Figure 5. Global Biopharmaceutical CMO and CRO Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biopharmaceutical CMO and CRO Revenue in 2023

Figure 7. Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Contract Manufacturing Picture

Figure 9. Contract Research Picture

Figure 10. Global Biopharmaceutical CMO and CRO Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Biopharmaceutical CMO and CRO Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Biologics Manuefacturing

Figure 13. Product Picture of Biosimilars Manuefacturing

Figure 14. Product Picture of Other

Figure 15. Global Biopharmaceutical CMO and CRO Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Biopharmaceutical CMO and CRO Sales Value Market Share by Application, 2023 & 2030

Figure 17. North America Biopharmaceutical CMO and CRO Sales Value (2019-2030) & (US$ Million)

Figure 18. North America Biopharmaceutical CMO and CRO Sales Value by Country (%), 2023 VS 2030

Figure 19. Europe Biopharmaceutical CMO and CRO Sales Value (2019-2030) & (US$ Million)

Figure 20. Europe Biopharmaceutical CMO and CRO Sales Value by Country (%), 2023 VS 2030

Figure 21. Asia Pacific Biopharmaceutical CMO and CRO Sales Value (2019-2030) & (US$ Million)

Figure 22. Asia Pacific Biopharmaceutical CMO and CRO Sales Value by Country (%), 2023 VS 2030

Figure 23. South America Biopharmaceutical CMO and CRO Sales Value (2019-2030) & (US$ Million)

Figure 24. South America Biopharmaceutical CMO and CRO Sales Value by Country (%), 2023 VS 2030

Figure 25. Middle East & Africa Biopharmaceutical CMO and CRO Sales Value (2019-2030) & (US$ Million)

Figure 26. Middle East & Africa Biopharmaceutical CMO and CRO Sales Value by Country (%), 2023 VS 2030

Figure 27. Key Countries/Regions Biopharmaceutical CMO and CRO Sales Value (%), (2019-2030)

Figure 28. United States Biopharmaceutical CMO and CRO Sales Value, (2019-2030) & (US$ Million)

Figure 29. United States Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

Figure 30. United States Biopharmaceutical CMO and CRO Sales Value by Application (%), 2023 VS 2030

Figure 31. Europe Biopharmaceutical CMO and CRO Sales Value, (2019-2030) & (US$ Million)

Figure 32. Europe Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

Figure 33. Europe Biopharmaceutical CMO and CRO Sales Value by Application (%), 2023 VS 2030

Figure 34. China Biopharmaceutical CMO and CRO Sales Value, (2019-2030) & (US$ Million)

Figure 35. China Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

Figure 36. China Biopharmaceutical CMO and CRO Sales Value by Application (%), 2023 VS 2030

Figure 37. Japan Biopharmaceutical CMO and CRO Sales Value, (2019-2030) & (US$ Million)

Figure 38. Japan Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

Figure 39. Japan Biopharmaceutical CMO and CRO Sales Value by Application (%), 2023 VS 2030

Figure 40. South Korea Biopharmaceutical CMO and CRO Sales Value, (2019-2030) & (US$ Million)

Figure 41. South Korea Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

Figure 42. South Korea Biopharmaceutical CMO and CRO Sales Value by Application (%), 2023 VS 2030

Figure 43. Southeast Asia Biopharmaceutical CMO and CRO Sales Value, (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

Figure 45. Southeast Asia Biopharmaceutical CMO and CRO Sales Value by Application (%), 2023 VS 2030

Figure 46. India Biopharmaceutical CMO and CRO Sales Value, (2019-2030) & (US$ Million)

Figure 47. India Biopharmaceutical CMO and CRO Sales Value by Type (%), 2023 VS 2030

Figure 48. India Biopharmaceutical CMO and CRO Sales Value by Application (%), 2023 VS 2030

Figure 49. Biopharmaceutical CMO and CRO Industrial Chain

Figure 50. Biopharmaceutical CMO and CRO Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

CDMO Market

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26N13078

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3L13782

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26S13718

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16S12875

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions